Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 28, 2022--
The "Clinical Trials Market Research Report by Design (Interventional Study and Observational Study), Phase, Indication, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Clinical Trials Market size was estimated at USD 32.27 billion in 2021, USD 35.14 billion in 2022, and is projected to grow at a CAGR 9.05% to reach USD 54.30 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Clinical Trials to forecast the revenues and analyze the trends in each of the following sub-markets:
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Market Dynamics
Drivers
Restraints
Opportunities
Challenges
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Clinical Trials Market, by Design
7. Clinical Trials Market, by Phase
8. Clinical Trials Market, by Indication
9. Americas Clinical Trials Market
10. Asia-Pacific Clinical Trials Market
11. Europe, Middle East & Africa Clinical Trials Market
12. Competitive Landscape
13. Company Usability Profiles
14. Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/dokxnj
View source version on businesswire.com:https://www.businesswire.com/news/home/20220928005802/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.comFor E.S.T. Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD: UNITED STATES MIDDLE EAST AFRICA LATIN AMERICA SOUTH AMERICA CENTRAL AMERICA NORTH AMERICA ASIA PACIFIC EUROPE
INDUSTRY KEYWORD: RESEARCH GENERAL HEALTH PHARMACEUTICAL ONCOLOGY INFECTIOUS DISEASES CLINICAL TRIALS SCIENCE CARDIOLOGY BIOTECHNOLOGY OTHER SCIENCE HEALTH DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/28/2022 10:50 AM/DISC: 09/28/2022 10:51 AM
http://www.businesswire.com/news/home/20220928005802/en